Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00025233
What this trial is testing

Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Squamous Cell CarcinomaRecurrent Cervical Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT03466099
What this trial is testing

Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME)

Who this might be right for
Diabetic Macular Edema
KalVista Pharmaceuticals, Ltd. 129
Large-scale testing (Phase 3)Study completedNCT02634333
What this trial is testing

Anti-VEGF Treatment for Prevention of PDR/DME

Who this might be right for
Diabetic RetinopathyDiabetic Macular Edema
Jaeb Center for Health Research 399
Not applicableStudy completedNCT01363570
What this trial is testing

Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes

Who this might be right for
Age Related Macular Degeneration
McMaster University 70
Not applicableStudy completedNCT04685369
What this trial is testing

Effectiveness of Anti-VEGF Treatments in Wet AMD in Active Smokers

Who this might be right for
Wet Age-related Macular Degeneration
Brugmann University Hospital 148
Not applicableStudy completedNCT02933905
What this trial is testing

Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

Who this might be right for
Diabetic Macular EdemaVitreomacular InterfaceAnti-VEGF Treatment
Fundació Institut Germans Trias i Pujol 38
Testing effectiveness (Phase 2)Study completedNCT01610557
What this trial is testing

Ranibizumab and Bevacizumab for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
National Eye Institute (NEI) 56
Early research (Phase 1)Study completedNCT00786383
What this trial is testing

Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy

Who this might be right for
Cancer
Eli Lilly and Company 25
Testing effectiveness (Phase 2)Study completedNCT01016873
What this trial is testing

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD

Who this might be right for
AMDWet AMDAge-Related Macular Degeneration+4 more
Oraya Therapeutics, Inc. 230
Not applicableLooking for participantsNCT07224841
What this trial is testing

Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC

Who this might be right for
CRC (Colorectal Cancer)
City of Hope Medical Center 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449222
What this trial is testing

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

Who this might be right for
Locally Advanced Breast CancerTriple Negative Breast CancerMetastatic Triple Negative Breast Cancers
BioNTech SE 83
Not applicableLooking for participantsNCT07722910
What this trial is testing

Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma

Who this might be right for
Neovascular GlaucomaType 2 Diabetes
Qilu Hospital of Shandong University 98
Not applicableUnknownNCT04952688
What this trial is testing

Modifications in Retinal Microvascularization With Targeted Anti-angiogenic Therapy in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Georges Francois Leclerc 30
Large-scale testing (Phase 3)Study completedNCT03143192
What this trial is testing

Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser

Who this might be right for
Diabetic Macular Edema
Keyvan Koushan 31
Testing effectiveness (Phase 2)UnknownNCT04749394
What this trial is testing

Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

Who this might be right for
Locally Advanced Non-Small Cell Lung Cancer
Chinese Academy of Medical Sciences 42
Post-approval studies (Phase 4)UnknownNCT01213667
What this trial is testing

Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD

Who this might be right for
Macular Degeneration
University of Cologne 110
Testing effectiveness (Phase 2)Ended earlyNCT02398500
What this trial is testing

Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
Alcon Research 25
Not applicableStudy completedNCT01428388
What this trial is testing

Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Barnes Retina Institute 150
Not applicableStudy completedNCT02979665
What this trial is testing

Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 51
Not applicableUnknownNCT06243406
What this trial is testing

Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Beijing Hospital 80
Next Page